Thursday, May 14, 2026 | 08:22 PM ISTहिंदी में पढें
Emcure Pharmaceuticals Ltd
Board Meeting Intimation for Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30 2025.
05:47 PM, 28th Jul 2025
Emcure Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2025 inter alia to consider and approve unaudited financial results (standalone and consolidated) for the quarter ended June 30 2025.